Onyx Bridge Wealth Group’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
AIM
FWIA
DLA
Onyx Bridge Wealth Group's BMY Position: Q2 2026 in Review
Onyx Bridge Wealth Group reduced its Bristol-Myers Squibb (BMY) stake by 0.36% in Q2 2026, selling an estimated $1.67K and leaving 8,126 shares worth $468K. The position accounts for 0.04% of the portfolio, ranked #246.
Onyx Bridge Wealth Group first reported a position in BMY in Q3 2021 and has held it in 20 quarters since. The position peaked at $895K in Q4 2024. 888 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- Onyx Bridge Wealth Group held 8,126 shares of Bristol-Myers Squibb worth $468K as of Q2 2026.
- Onyx Bridge Wealth Group sold 29 Bristol-Myers Squibb shares in Q2 2026, an estimated $1.67K.
- Bristol-Myers Squibb made up 0.04% of Onyx Bridge Wealth Group's portfolio in Q2 2026, its #246 holding.
- Onyx Bridge Wealth Group first reported a position in Bristol-Myers Squibb in Q3 2021 and has held it in 20 quarters since.
- Onyx Bridge Wealth Group's Bristol-Myers Squibb position peaked at $895K in Q4 2024.
- 888 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on Onyx Bridge Wealth Group's 13F filing for Q2 2026, filed 23 Jul 2026.